Newsletter – March 2nd 2023
NEWSLETTER: Nasally Delivered Dry Powder Dosage Forms: Particle Size Analysis Introduction to Nasal Delivery The delivery of APIs via nasal inhalation is of growing interest
Menu
Your CDMO Specialist
Supporting You From Feasibility To Clinic
Upperton Pharma Solutions is an early phase Pharmaceutical Contract Development and Manufacturing Organisation (CDMO) with more than twenty years of experience in the development of pharmaceutical dosage forms.
We offer our clients an extensive range of services, from early feasibility to dosage form development and clinical trial manufacturing.
Pre-Formulation Studies
Upperton’s formulation development team will confidently guide you on the best route forward.
Formulation Development
Utilise our expertise and know-how to solve problems unique to your challenging molecule.
Clinical Manufaturing
FIH through to phase II clinical
manufacturing. No project is too small or too challenging.
Can we help you?
Latest news
Newsletter – January 31st 2023
NEWSLETTER: What’s New In 2023: ExcitingPlans For Upperton Pharma Solutions! The New Year is always a time for looking ahead and 2023 will no doubt
18th January 2023 – Upperton Pharma Solutions breaks ground on new Nottingham based development and manufacturing facility
Upperton Pharma Solutions breaks ground on new Nottingham based development and manufacturing facility Nottingham : 18th January 2023 Upperton Pharma Solutions, a leading UK contract